Conclusion
This case highlights the importance of closely monitoring medication
induced hematologic side effects. Phenazopyridine is not a benign
medication when used for prolonged periods of time and can induce
hemolysis. Physicians and care providers must remain mindful of using
phenazopyridine for symptomatic HC related dysuria.
Disclosures of funding : None